| View |
|
DR-XY44285
|
Montelukast (as sodium)
|
Montril-10
|
10 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist
|
Aristopharma Ltd.
|
Bangladesh
|
Renewal
|
09 November 2024
|
28 January 2030
|
| View |
|
DR-XY44287
|
Vitamin B1 + B6 + B12
|
Plexivit
|
100mg/200mg/200mcg
|
Tablet
|
Vitamin
|
Jiangxi Xier Kangtai Pharmaceutical Co., Ltd.
|
China
|
-
|
08 April 2020
|
16 March 2025
|
| View |
|
DR-XY44288
|
Citicoline (as Sodium)
|
Miracoline
|
1g
|
Film-Coated Tablet
|
Physcostimulant/Nootropic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
21 October 2024
|
13 March 2030
|
| View |
|
DR-XY44289
|
Sodium Fusidate
|
Fusidane
|
20mg/g (2%w/w)
|
Ointment
|
-
|
Dongkwang Pharm. Co., Ltd.
|
Korea
|
-
|
02 January 2020
|
13 March 2025
|
| View |
|
DR-XY44294
|
Cefixime (As Trihydrate)
|
Vamocef
|
200 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
06 October 2020
|
13 April 2025
|
| View |
|
DR-XY44304
|
Clonidine Hydrochloride
|
Clonin
|
150 mcg
|
Tablet
|
Antihypertensive
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
02 November 2024
|
19 March 2030
|
| View |
|
DR-XY44308
|
Levofloxacin
|
Iflox
|
5mg/mL
|
Ophthalmic Solution (Eye Drops)
|
-
|
Unimed Pharma Inc.
|
Korea
|
-
|
22 January 2020
|
19 March 2025
|
| View |
|
DR-XY44310
|
Epinephrine (As Hydrochloride)
|
Epix
|
1 mg/mL
|
Solution For Injection (I.M./I.V./S.C.)
|
Adrenergic/Dopaminergic Agent
|
Grand Pharmaceutical (China) Co., Ltd.
|
China
|
Initial (Variation)
|
17 May 2022
|
17 May 2027
|
| View |
|
DR-XY44313
|
Zinc Sulfate Monohydrate
|
None
|
55 mg / 5 mL (Equi. To 20mg Elemental Zinc)
|
Syrup
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
01 April 2020
|
12 March 2025
|
| View |
|
DR-XY44329
|
Irbesartan
|
IRBEZ 300
|
300 mg
|
Tablet
|
Antihypertensive [Angiotensin II Receptor Blocker (ARB)]
|
Unison Laboratories Co., Ltd.
|
Thailand
|
Renewal
|
02 November 2024
|
16 March 2030
|
| View |
|
DR-XY44337
|
Nitrofurantoin
|
Nitro
|
100 mg
|
Capsule
|
-
|
West-Coast Pharma., Works Ltd.
|
India
|
-
|
23 April 2020
|
23 March 2025
|
| View |
|
DR-XY44342
|
Fat Emulsion + Amino Acids with Electrolytes + Glucose
|
MG TNA-PERI
|
20% / 11.3% / 11%
|
Admixture Solutions for Peripheral Infusion
|
-
|
MG Co., Limited
|
Korea
|
-
|
10 January 2022
|
06 December 2026
|
| View |
|
DR-XY44343
|
Cetirizine Hydrochloride
|
Rhinil
|
10 mg
|
Film-Coated Tablet
|
-
|
Aristopharma Ltd.
|
Bangladesh
|
-
|
02 April 2020
|
19 March 2025
|
| View |
|
DR-XY44348
|
Telmisartan
|
Unbranded
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
13 October 2024
|
19 March 2030
|
| View |
|
DR-XY44350
|
Ascorbic Acid
|
C-4 Kids
|
100 mg (equivalent to 112.5 mg Sodium Ascorbate) 5 mL
|
Syrup
|
Vitamin
|
Drugmakers Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
02 February 2022
|
19 March 2027
|
| View |
|
DR-XY44353
|
Perampanel
|
Fycompa
|
2 mg
|
Film-Coated Tablet
|
Antiepileptic
|
Eisai Manufacturing Limited
|
United Kingdom
|
Renewal
|
27 April 2024
|
24 March 2030
|
| View |
|
DR-XY44354
|
Perampanel
|
Fycompa
|
4mg
|
Film-Coated Tablet
|
Anti-epileptic
|
Eisai Manufacturing Limited
|
United Kingdom
|
Initial from Monitored Release]
|
19 October 2021
|
24 March 2025
|
| View |
|
DR-XY44359
|
Cefoperazone (As Sodium) + Sulbactam (As Sodium)
|
Sulbacef
|
1g/500mg
|
Powder For Injection (IV/IM)
|
-
|
Cosmas Research Lab Ltd.
|
India
|
-
|
06 April 2020
|
25 March 2025
|
| View |
|
DR-XY44362
|
Glipizide
|
Glibetic
|
5mg
|
Tablet
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
-
|
18 June 2020
|
25 March 2025
|
| View |
|
DR-XY44364
|
Allopurinol
|
Eonex 100
|
100 mg
|
Tablet
|
-
|
Helviina Pharmaceuticals Pvt. Ltd.
|
India
|
-
|
19 June 2020
|
15 April 2025
|